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Abstract
Neuronal inhibition is mediated by glycine and/or GABA. Inferior colliculus (IC) neurons receive glycinergic and GABAergic
inputs, whereas inhibition in hippocampus (HC) predominantly relies on GABA. Astrocytes heterogeneously
express neurotransmitter transporters and are expected to adapt to the local requirements regarding neurotransmitter
homeostasis. Here we analyzed the expression of inhibitory neurotransmitter transporters in IC and HC astrocytes using
whole-cell patch-clamp and single-cell reverse transcription-PCR. We show that most astrocytes in both regions expressed
functional glycine transporters (GlyTs). Activation of these transporters resulted in an inward current (IGly) that
was sensitive to the competitive GlyT1 agonist sarcosine. Astrocytes exhibited transcripts for GlyT1 but not for
GlyT2. Glycine did not alter the membrane resistance (RM) arguing for the absence of functional glycine receptors (GlyRs).
Thus, IGly was mainly mediated by GlyT1. Similarly, we found expression of functional GABA transporters (GATs) in all IC
astrocytes and about half of the HC astrocytes. These transporters mediated an inward current (IGABA) that was sensitive to
the competitive GAT-1 and GAT-3 antagonists NO711 and SNAP5114, respectively. Accordingly, transcripts for GAT-1 and
GAT-3 were found but not for GAT-2 and BGT-1. Only in hippocampal astrocytes, GABA transiently reduced
RM demonstrating the presence of GABAA receptors (GABAARs). However, IGABA was mainly not contaminated
by GABAAR-mediated currents as RM changes vanished shortly after GABA application. In both regions, IGABA
was stronger than IGly. Furthermore, in HC the IGABA/IGly ratio was larger compared to IC. Taken together, our
results demonstrate that astrocytes are heterogeneous across and within distinct brain areas. Furthermore, we
could show that the capacity for glycine and GABA uptake varies between both brain regions.
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Introduction
Glycine and GABA mediate synaptic inhibition in ma-
tured circuits. Glycinergic and GABAergic inhibition are
attributed predominantly to caudal and rostral brain re-
gions, respectively. Nonetheless, both neurotransmitters
coexist throughout the whole brain.
Mixed inhibitory synaptic transmission, with co-release
of glycine and GABA from the same presynaptic terminal,
takes place in various caudal brain regions, such as audi-
tory brainstem, ventral respiratory group, cerebellum, and
spinal cord [1–8]. In more rostral brain regions, like the
hippocampus (HC), GABA is utilized for inhibitory synap-
tic transmission [9, 10], while glycine co-released from
glutamatergic terminals can modulate NMDA receptor
(NMDAR)-mediated signaling [11, 12]. Accordingly,
glycine transporters (GlyTs) and GABA transporters
(GATs) are widely expressed in astrocytes and neurons
[13–16] to enable neurotransmitter clearance, reuptake,
and modulation of neuronal signaling [15, 17, 18]. Astro-
cytes mainly express GlyT1 (Slc6A9), GAT-1 (Slc6A1),
and/or GAT-3 (Slc6A11), which mediate an inward
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current and concomitant depolarization [19]. In addition,
astrocytes can express ionotropic receptors for glycine
(GlyRs) and GABA (GABAARs) [20–26].
In a previous study, we analyzed the expression of func-
tional GlyTs and GATs in astrocytes in the lateral superior
olive (LSO) – a conspicuous auditory brainstem center
whose main inhibitory input is glycinergic after early post-
natal development [2, 3]. Astrocytes in this nucleus ex-
press functional GlyT1, GAT-1, and GAT-3 [19]. To study
the region-dependent heterogeneity of GlyT and GAT ex-
pression in astrocytes, we chose two systems that contrast
the LSO with respect to the utilization of glycine and
GABA for inhibitory synaptic transmission: 1) The inferior
colliculus (IC) residing in the midbrain belongs to the ros-
tral part of the auditory brainstem and serves as a major
hub for processing auditory cues [4, 27]. Afferents from all
auditory brainstem centers converge in the lateral lemnis-
cal tract (LL) and project to the IC (Fig. 1a) [4, 8, 28]. The
inhibitory part of the tract consists of glycinergic and
GABAergic projections [8, 29–31]. Accordingly, IC astro-
cytes can be proposed to express GlyTs and GATs to ac-
count for neurotransmitter uptake. GlyT1 expression was
found in the IC and attributed to glial cells [11, 13, 32].
Likewise, GAT-1 and GAT-3 are present in the IC [33,
34]. However, GlyTs and GATs in IC astrocytes have not
yet been electrophysiologically characterized. 2) The HC is
the second system of interest. Whereas its main circuitry
is glutamatergic [35, 36], inhibitory synaptic transmission
arises from GABAergic interneurons [9, 10]. In line with
this, astrocytes in the stratum radiatum express GAT-3,
whereas GAT-1 has been attributed to interneurons [21,
37]. Glycine is co-released from glutamatergic terminals
and modulates NMDAR-mediated signaling [11, 12]. For
uptake of released glycine, GlyT1 is expressed in astro-
cytes and presynaptic terminals [11, 38–40]. However,
functionality of GlyT1 in HC astrocytes has not been
demonstrated prior to this study.
Here we analyzed the heterogeneity of expression
and function of inhibitory neurotransmitter trans-
porters in astrocytes from IC and HC. Using whole-
cell patch-clamp recordings from sulforhodamine
101 (SR101)-labeled astrocytes [19, 41, 42] and con-
comitant application of glycine or GABA to provoke
transporter activation, together with single-cell re-
verse transcription (RT)-PCR, our results demon-
strate that all IC astrocytes and about half of the
HC astrocytes expressed functional GlyT1, GAT-1,
and GAT-3. In contrast, GlyT2, GAT-2, and BGT-1
were never found. From our experiments, we can ex-
clude that transporter currents were contaminated
by respective ionotropic receptor-mediated currents.
As expected, GAT activity was much stronger in HC
astrocytes compared to IC astrocytes. Concurrently,
our results show that IC and HC astrocytes exhibit
heterogeneous properties, which reflect region-specific
adaptation to local circuitry.
Methods
Preparation of acute tissue slices and labeling of
astrocytes
We used tissue from C57BL/6 wild type mice of both
genders at postnatal days 10-12 for our experiments.
Mice were treated in accordance with the German law
for conducting animal experiments and the NIH guide-
lines for the care and use of laboratory animals. Acute
coronal slices were retrieved from midbrain and fore-
brain containing IC and HC, respectively. After decapi-
tation, the brain was quickly transferred into ice-cold
cutting solution containing (in mM): 26 NaHCO3, 1.25
NaH2PO4, 2.5 KCl, 1 MgCl2, 2 CaCl2, 260 D-glucose, 2
Na-pyruvate, and 3 myo-inositol, pH 7.4, bubbled with
carbogen (95% O2, 5% CO2). 270 μm thick slices were
cut using a vibratome (VT1200 S, Leica). Thereafter,
slices were transferred to artificial cerebrospinal fluid
(ACSF) containing (in mM): 125 NaCl, 25 NaHCO3,
1.25 NaH2PO4, 2.5 KCl, 1 MgCl2, 2 CaCl2, 10 D-glucose,
2 Na-pyruvate, 3 myo-inositol, and 0.44 ascorbic acid,
pH 7.4, bubbled with carbogen. Slices were incubated
for 30 min at 37 °C in 0.5-1 μM SR101 and washed for
another 30 min at 37 °C in SR101-free ACSF. This re-
sulted in reliable labeling of astrocytes as shown before
[19, 41]. Thereafter, slices were kept at room
temperature (20-24 °C). All chemicals were purchased
from Sigma-Aldrich or AppliChem, if not stated
otherwise.
Electrophysiology
Whole-cell patch-clamp experiments were done as de-
scribed before [19]. Briefly, the recording chamber was
placed at an upright microscope equipped with infrared dif-
ferential interference contrast (Eclipse FN1, Nikon, 60×
water immersion objective, N.A. 1.0) and an infrared video
camera (XC-ST70CE, Hamamatsu). Voltages and currents
were recorded using a double patch-clamp EPC10 amplifier
and PatchMaster software (HEKA Elektronik). The patch
pipettes were pulled from borosilicate glass capillaries
(GB150(F)-8P, Science Products) using a horizontal puller
(P-87, Sutter Instruments). Pipettes had a resistance of
3-7 MΩ using an intracellular solution containing (in mM):
140 K-gluconate, 5 EGTA (glycol-bis(2-aminoethylether)-
N,N′,N′,N′-tetraacetic acid), 10 Hepes (N-(2-hydro-
xyethyl)piperazine-N′-2-ethanesulfonic acid), 1 MgCl2, 2
Na2ATP, and 0.3 Na2GTP, pH 7.30. In some experiments
the intracellular solution contained biocytin (0.3%, Biomol)
or alexa fluor (AF) 568 (100 μM, Invitrogen) to allow the
postfixational reconstruction of IC and HC neurons,
respectively. Biocytin was labeled with NeutrAvidin-
horseradish peroxidase conjugate (1:1000; Invitrogen) [43].
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Fig. 1 Identification of IC and HC astrocytes. a, d: Semischematic drawings of coronal sections containing the central nucleus of the IC together
with the lateral lemniscal tract (LL) (A) and the CA1 region of the HC (CA: cornu ammonis; GD: gyrus dentatus; SO: stratum oriens; SP: stratum
pyramidale; SR: stratum radiatum; SLM: stratum lacunosum moleculare). b, e: SR101-labeled cells (astrocytes) were widely distributed within the IC
(b) and the HC (e). They exhibited a small soma and were highly branched (insets in b and e; scale bar: 10 μm). c, f: Astrocytes were clamped to
EH = −85 mV and were stepwise hyper- and depolarized from −150 mV to +50 mV, with 10 mV increments. Membrane currents were recorded
(top) and leak currents were subtracted (p/4; bottom). Non-passive astrocytes (nPA) expressed time- and voltage-dependent outward currents
(c1, f1), whereas passive astrocytes (PA) lacked these currents (c2, f2). About 2/3 of IC astrocytes were passive (c3), whereas it was the opposite in
the HC (f3). n represents the number of recorded cells
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Astrocytes and neurons in the central nucleus of the
IC (Fig. 1a; Additional file 1: Figure S1A1) and CA1 re-
gion of the HC (Fig. 1d; Additional file 1: Figure S1A2)
were clamped to a holding potential (EH) of −85 mV and
−70 mV, respectively. The cells were hyper- and depolar-
ized using a standard step protocol ranging from −150
to +50 mV with 10 mV increments. The resulting
current traces were sampled at 50 kHz. We performed a
standard leak subtraction protocol (p/4) to isolate cur-
rents mediated by voltage-activated channels. Four step
protocols were executed repetitively that comprised a re-
duced step size of 25%. Thereafter, the recorded current
traces were add together and subtracted from the initial
recording (Fig. 1c1-2, f1-2, Additional file 1: Figure S1B).
Glycine and GABA, both 1 mM in ACSF, were applied in
two ways: 1) In experiments analyzing the maximal
neurotransmitter-induced current and depolarization
(Figs. 2 and 4) both transmitters were administered using a
peristaltic pump (Reglo, Ismatec) at a rate of 1-2 ml/min.
Data were sampled at 100 Hz. We monitored putative
changes of membrane resistance (RM) and series resistance
(RS) every 30 s (≙ 0.033 Hz) using hyperpolarizing test
pulses (ΔU = 5 mV) [44]. The resulting currents were sam-
pled at 20 kHz. 2) When pharmacologically isolating trans-
porters mediating membrane currents (Figs. 3a and 5a)
neurotransmitters were applied via focal pressure
injection (PDES-2 T, NPI; 12 psi). Therefore, a pipette
with a resistance of 3-7 MΩ was filled with glycine or
GABA and positioned approximately 20 μm apart from
the recorded cell [19]. Membrane currents were
sampled at 1 kHz. In order to detect additionally short-
lasting receptor-mediated changes in membrane con-
ductance during focal application of neurotransmitters
(Figs. 3c and 5c, Additional file 2: Figure S2B-E), hyper-
polarizing test pulses were applied at 1 Hz (Additional
file 2: Figure S2A) and RM of astrocytes and neurons
was calculated [44]. All recordings were low-pass filtered
at 2.9 kHz. Data were processed and analyzed using
“IGOR Pro 6.2” software (Wavemetrics). Measure-
ments were rejected if RS exceeded 15 MΩ.
Single-cell RT-PCR
The patch pipette was filled with 3 μl of intracellular
solution. Next, astrocytes were patch-clamped as de-
scribed in the preceding paragraph. After determination
of the I-V relationship, the cytoplasm was sucked into the
patch pipette, which was then retracted from the slice.
The remaining cell parts were sucked into the patch pip-
ette and the intracellular solution containing the cyto-
plasm was put into a 50 μl PCR reaction tube containing
Fig. 2 Glycine-induced transients in IC and HC astrocytes. a-b: Application of glycine (1 mM) caused an inward current (IGly (max); EH = −85 mV; a1-2)
and a membrane depolarization (ΔEM; b1-2), which was not different between IC and HC astrocytes (a3, b3). The number of recorded cells (n) is given
within the diagrams. Shown are mean values ± SEM. Significance levels in panels a3 and b3 were Šidák corrected for two comparisons
(see Methods section)
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3 μl of diethyl pyrocarbonate (0.1%)-treated water (Ther-
moFisher Scientific). To avoid degradation by RNAse ac-
tivity the sample was immediately frozen in liquid
nitrogen and stored at −80 °C. Samples were rejected, if
the patch was unstable during cell extraction or fragments
from neighboring cells stuck at the pipette.
For transcription of mRNA into cDNA reverse
transcriptase (SuperScript III, 100 U; ThermoFisher
Scientific), RNAse inhibitor (RNAseOUT, 40 U; Ther-
moFisher Scientific), random hexamers (50 μM, Ther-
moFisher Scientific), first-strand buffer (ThermoFisher
Scientific), and dithiothreitol (DTT; 10 mM; Thermo-
Fisher Scientific) were added to the frozen sample (total
volume: 13 μl). Next, RT was performed for 1 h at 37 °C.
Subsequently, a multiplex PCR was performed to iden-
tify transcripts of inhibitory neurotransmitter trans-
porters. MPprimer software [45] was used to create
primer sequences (Table 1). Primers were chosen to be
located on different exons. Thus, amplification of DNA,
which contains exons and introns, would result in larger
product length compared to the amplicon of spliced
mRNA that could be distinguished after gel electrophor-
esis. The PCR reaction mix contained: 5× PCR buffer
including dNTPs (50 μM; Bioline), Taq Polymerase (4 U,
Bioline), 200 nM primers (Eurofins Scientific), 10 μl of
the RT reaction product, H2O (ad 50 μl, Ampuwa, Fre-
senius Kabi). Fifty PCR cycles were performed: denatur-
ation for 25 s at 94 °C, annealing for 2 min (first
5 cycles) and 45 s (subsequent 45 cycles) at 51 °C, and
elongation for 25 s at 72 °C. Afterwards, a second PCR
with nested primers and 40 cycles was conducted: de-
naturation for 25 s at 94 °C, annealing for 2 min (first
5 cycles) and 45 s (subsequent 35 cycles) at 54 °C, and
elongation for 25 s at 72 °C. The second PCR reaction
mix contained Platinum Taq Polymerase (1 U, Thermo-
Fisher Scientific), 10× PCR buffer (MgCl2-free; Thermo-
Fisher Scientific), 2.5 mM MgCl2 (ThermoFisher
Scientific), 50 μM dNTPs (Bioline), nested primers
(200 nM, Eurofins Scientific), and 2 μl of the first PCR
reaction product.
Fig. 3 IC and HC astrocytes express GlyT1. a: Focal application of glycine (1 mM, 0.5 s; triangles) elicited an IGly (EH = −85 mV; a1-2). The competitive
GlyT1 agonist sarcosine (2 mM) reduced IGly (max) (a3). b: Single-cell RT-PCR revealed transcripts for GlyT1 in all IC astrocytes and about half of the HC
astrocytes. Transcripts for GlyT2 were not found. c: Focal application of glycine (1 mM, 10 s; triangle) induced a long lasting inward current
(EH = −85 mV; c1-2, top). Responses to test pulse (see Additional file 2: Figure S2A) were used to calculate RM at t0, t1, t5, and t10 (c1-2, bottom).
Upon glycine application, RM was not reduced in IC and HC astrocytes (c3). The number of recorded cells (n) is given within the diagrams.
Shown are mean values ± SEM. Significance levels in c3 were Šidák corrected for three comparisons (see Methods section). bp: base pairs
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Positive controls were performed with mRNA extracted
from mouse brainstem by using an mRNA extraction kit
(Dynabeads mRNA Purification Kit, Invitrogen; Add-
itional file 3: Figure S3). For negative controls, the patch
pipette was positioned close to the tissue in the recording
chamber and ACSF was sucked into the pipette. Subse-
quently, the probe was frozen in liquid nitrogen and used
for RT-PCR (Additional file 3: Figure S3). All amplified
PCR products were loaded on an agarose gel (1.5%),
labeled with 1% ethidium bromide (Carl Roth), and ana-
lyzed using a transilluminator (Biometra TI 1). To deter-
mine the PCR product length we used a standard DNA
ladder (HyperLadder 50 bp, Bioline).
Initial experiments showed that some HC astrocytes
were devoid of any target RNA (GlyTs or GATs). To prove
successful RNA extraction from HC astrocytes transcripts
for the inwardly rectifying K+ (Kir) channel 4.1 were de-
tected, which are present in all HC astrocytes [46].
Confocal microscopy
The labeling with SR101 - used for a priori identification
of IC and HC astrocytes - and AF568 was documented
as described before [41] using a confocal microscope
(Leica TCS SP5 LSM: HC PL FLUOTAR 10 × 0.30 DRY;
HCX PL APO Lambda blue 63 × 1.4 OIL UV) and LAS
AF software. Fluorophores were detected as follows (ex-
citation wavelength/filtered emission wavelength): SR101
(SP5: 561 nm/580-620 nm) and AF568 (561 nm/580-
620 nm). To improve the quality of confocal micro-
graphs and reduce background fluorescence, we used a
Kalman filter (averaging of four identical image sec-
tions). Images were processed using Fiji software [47].
Statistics
Results were statistically analyzed using WinSTAT (R. Fitch
Software). Data were tested for normal distribution with
Kolmogorov-Smirnov test. In case of normal distribution,
results were assessed by one-tailed, paired or non-paired
Student’s t-tests. In the absence of a normal distribution, re-
sults were assessed by Wilcoxon test for paired or U-test
(Mann-Whitney) for non-paired data. P represents the
error probability, *P < 0.05, **P < 0.01, ***P < 0.001; n repre-
sents the number of experiments or cells/slices/animals. In
case of multiple comparisons data were statistically ana-
lyzed by the tests described above under post hoc Šidák
correction of critical values [48]: two comparisons: Fig. 2a3,
Table 1 Primers for single-cell RT-PCR
Gene Sequence Expected amplicon size [bp] GeneBank accession number
GlyT1 fwd 5’-CACCAACTGTGCTACCAGCGTCTA-3′
rev 5’-GCATAGTTGTCCATCAGCAGCAGC-3’
390 NM_008135.4
GlyT1 (nested) fwd 5’-GCTTCGTCATCTTCTCCATCCTG-3′
rev 5’-CAGTAGATGCCTGCCTGGCTG-3’
337
GlyT2 fwd 5’-TCCTGTGTTATCGGTGACCATCC-3′
rev 5’-GAGTGGCCGCATCCTTCCATA-3’
430 NM_148931.3
GlyT2 (nested) fwd 5’-TCTGCATGACTGCCTATCCGAACT-3′
rev 5’-TGTGATGAAGTACCAGATGCCGG-3’
329
GAT-1 fwd 5’-GATGACAGATGGACTGGACAAG-3′
rev 5’-CACGATGGAGAAGATGACGAAT-3’
430 NM_178703.4
GAT-1 (nested) fwd 5‘-TTGGACTGGAAAGGTGGTCTA-3‘
rev 5’-ACGATGGAGAAGATGACGAATC-3’
324
GAT-2 fwd 5’-TTATTGTGTCCGTCATCTCGTT-3′
rev 5’-ACTTCTTGTTGTAGGTCAGTGG-3’
309 NM_144512.2
GAT-2 (nested) fwd 5’-GTTCTTCATCGGGCTCATCAT-3′
rev 5’-TAGGTCAGTGGCGTGTATTTG-3’
279
GAT-3 fwd 5’-GGGCATCTTCATCTTCTTTCTG-3′
rev 5’-GGTTCAGGATTCATTTACACGC-3’
390 NM_172890.3
GAT-3 (nested) fwd 5’-GGGCATCTTCATCTTCTTTCTG-3′
rev 5’-AGTGTGTCTCCTTCTCTGTGAT-3’
320
BGT-1 fwd 5’-ACTTTCTTCTTCTCCTTGAGCA-3′
rev 5’-CTCTGGCACTTCCTACAAATGA-3’
324 NM_133661.3
BGT-1 (nested) fwd 5’-ACTTTCTTCTTCTCCTTGAGCA-3′
rev 5’-ATGAGTTCTTGTTTGGCTGGA-3’
284
Kir4.1 fwd 5’-ACT TTC TTC TTC TCC TTG AGCA-3′
rev 5’-CTC TGG CAC TTC CTA CAA ATGA-3’
324 NM_001039484.1
Kir4.1 (nested) fwd 5’-ACT TTC TTC TTC TCC TTG AGCA-3′
rev 5′-ATG AGT TCT TGT TTG GCT GGA-3’
284
fwd Forward (/sence) primer, rev Reverse (/antisence) primer, bp Base pairs
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Fig. 4a3, Table 2; *P < 0.025, **P < 0.005, ***P < 0.0005; three
comparisons: Fig. 2c3, Fig. 4c3, Additional file 2: Figure
S2B3-E3, Table 3; *P < 0.017, **P < 0.0033, ***P < 0.0003.
Data are provided as mean ± SEM.
Results
Identification of IC and HC astrocytes
SR101 labeling is used in many different brain regions to
identify astrocytes in acute tissue slices [19, 41, 42]. We
mentioned before that incubation of acute slices with
SR101 results in labeling of putative astrocytes in the IC,
but we did not electrophysiologically confirm the identity
of these SR101+ cells [19]. In IC and HC (CA1, stratum
radiatum), SR101-labeled cells comprised a small sized
soma with several branching processes. In HC, these cells
exhibited strong branching, whereas in IC they appeared
to be less complex (Fig. 1b, e). The SR101-labeled cells
exhibited membrane properties of classical astrocytes, i.e.
a highly negative membrane potential (EM: IC: -84.2 ±
0.3 mV, n = 207/116/101; HC: -81.8 ± 0.4 mV, n = 109/83/
36) and a low RM (IC: 8.3 ± 0.7 MΩ, n = 207/116/101; HC:
9.7 ± 0.6 MΩ, n = 109/83/36). Due to the presence of
voltage-activated outward currents, non-passive and pas-
sive astrocytes were identified (IC: 28%/72%, n = 207/116/
101, HC: 59%/41%, n = 109/83/36, Fig. 1c, f ), which is
typical for that developmental stage.
GlyT expression in IC and HC astrocytes
Astrocytes in many brain regions express GlyTs [15],
whereas GlyRs are only rarely present [20, 22]. To analyze
the expression of functional GlyTs in IC and HC astro-
cytes, we first characterized the response of membrane
current and potential upon glycine bath application. The
wash-in caused a reversible glycine-induced inward
current (IGly) that usually peaked within the first minute
(IGly (max): IC: 173 ± 28 pA, n = 13/11/10; HC: 141 ± 20 pA,
n = 10/9/6; P = 0.200; Fig. 2a). Upon prolonged glycine ad-
ministration, IGly partially recovered to a newly formed
steady-state level in some recordings. Similarly, glycine in-
duced a reversible depolarization (ΔEM (Gly): IC: 3.0 ±
0.8 mV, n = 8/8/7; HC: 2.6 ± 0.5 mV, n = 6/6/5; P = 0.375;
Fig. 2b). To prove whether IGly and ΔEM (Gly) are mediated
by GlyT1, we focally applied glycine in the absence and
presence of sarcosine (Fig. 3a1-2). The competitive GlyT1
agonist itself caused an inward current by activation of the
transporter and subsequently competed with applied gly-
cine [19]. Sarcosine reduced IGly (max) by about 60-70%
(IC: 59 ± 2%, n = 12/5/5, P < 0.001; HC: 70 ± 4%, n = 4/4/2,
Fig. 4 GABA-induced transients in IC and HC astrocytes. a: Application of GABA (1 mM) caused an inward current (IGABA (max); EH = −85 mV; a1-2),
which was larger in HC astrocytes (a3). b: Similarly, GABA induced a membrane depolarization (ΔEM; b1-2), which was not significantly different
between IC and HC astrocytes (b3). Shown are mean values ± SEM. Significance levels in panel a3 and b3 were Šidák corrected for two comparisons
(see Methods section)
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P = 0.015; Fig. 3b3) showing the presence of functional
GlyT1 in IC and HC astrocytes.
As the inhibition of IGly (max) was incomplete and GlyT2
was occasionally reported to be present in astrocytes [40,
49], we analyzed transcripts for GlyTs in single astrocytes.
GlyT1 mRNA was detected in all IC astrocytes and about
half of the HC astrocytes (IC; n = 6/2/2; HC: n = 9/2/2;
Fig. 3b). GlyT2 was never found in astrocytes but in the
positive control (Additional file 3: Figure S3).
Interestingly, we never observed a glycine-induced
outward current or changes in RM (tested every 30 s ≙
0.033 Hz) upon the activation of putatively expressed GlyRs
(not shown). However, glycine-induced outward currents
and RM changes upon short term activation of GlyRs dur-
ing the first seconds of glycine wash-in might be over-
looked due to the relatively slow exchange of ACSF in the
recording chamber and concomitant slow rise of the neuro-
transmitter concentration in combination with receptor
desensitization [50]. Thus, bath application of glycine is not
a suitable approach to prove the presence of functional
GlyRs. Therefore, we designed a new protocol for fast and
focal pressure injection of neurotransmitters in combin-
ation with a voltage-clamp protocol including a higher fre-
quency of test pulses assessing RM changes now at 1 Hz
(Additional file 2: Figure S2A).
We first assessed the suitability of this protocol on
IC and HC neurons. Bipolar shaped IC neurons and
CA1 pyramidal cells (Additional file 1: Figure S1A)
expressed time- and voltage-dependent inward and
outward currents, respectively (Additional file 1: Fig-
ure S1B). Upon focal glycine application, IC neurons
and CA1 pyramidal cells exhibited a transient, fast
declining outward current (Additional file 2: Figure
S2B1, D1). This was paralleled by an increase in the
offset current induced by the test pulses resembling a
strong reduction of RM (IC: t1 − 97.9 ± 0.5%, n = 11/4/4,
P < 0.001; HC: t1 -41.2 ± 6.2%, n = 4/2/2, P = 0.004;
Additional file 2: Figure S2B2-3, D2-3). In the prolonged
presence of glycine, RM of IC neurons recovered partially,
whereas RM of CA1 pyramidal cells recovered completely
(IC: t10: −90.9 ± 2.5% of resting RM, P < 0.001 compared to
t0; P = 0.004 compared to t1; HC: t10: −4.5 ± 7.0% of
resting RM, P = 0.285 compared to t0; P = 0.006 com-
pared to t1). Both cases indicate desensitization of GlyRs
(Additional file 2: Figure S2B3, D3), as previously reported
for neurons in both regions [50, 51].
Subsequently, we used the focal application protocol
on IC and HC astrocytes. Glycine induced an inward but
no outward current at any time point during the 10 s
application (Fig. 3c1-2). Furthermore, the offset current
induced by the test pulses did not change. At t1 (1 s after
glycine application), RM was not reduced (IC: +8.4 ±
3.6%, n = 15/4/4, P = 0.018; HC: +2.9 ± 4.0%, n = 6/5/3,
P = 0.252; Fig. 3c3). Thus, RM was glycine-independent
arguing against an activation of GlyRs. Taken together, IC
and HC astrocytes expressed functional GlyT1, whereas
GlyRs were only present in IC and HC neurons. Data are
summarized in Tables 2 and 3.
GAT expression in IC and HC astrocytes
GATs are present in astrocytes of various brain regions
[15, 16]. Here, we analyzed the expression of different
functional GATs in IC and HC astrocytes. GATs and
GABAARs mediate – under our experimental conditions
– an inward and outward current, respectively. The
wash-in of GABA induced a transient inward current
(IGABA) that peaked usually within the first minute
(IGABA (max); Fig. 4a1-2). Notably, IGABA (max) was larger
in HC astrocytes (IC: 327 ± 35 pA, n = 14/11/10; HC:
504 ± 67 pA, n = 7/7/5; P = 0.009; Fig. 4a3). Upon
Table 2 Glycine- and GABA-induced inward current and depolarization in IC and HC astrocytes
Region IGly (max) [pA] P IGABA (max) [pA] P Ratio P ΔEM (Gly) [mV] P ΔEM (GABA) [mV] P Ratio P
IC 173 ± 28 (13)
0.200
n.s. sc
327 ± 35 (14)
0.009
* sc
1.9 0.002
** sc
3.0 ± 0.8 (8)
0.374
n.s. sc
7.2 ± 0.8 (7)
0.041
n.s. sc
2.4 0.003
** sc
HC 141 ± 20 (10) 504 ± 67 (7) 3.6 0.001
** sc
2.6 ± 0.5 (6) 10.6 ± 1.6 (7) 4.1 0.002
** sc
The data are given as mean ± SEM. The number of experiments is given in parenthesis. IC Inferior colliculus, HC Hippocampus, P Probability value, sc Šidák corrected
significance level for 2 comparisons, n.s. Not significant, *sc: P < 0.025, **P < 0.005. For critical significance levels, see Methods section
Table 3 The effect of glycine and GABA on astrocytic and neuronal membrane resistance
Region Cell type ΔRM (Gly) [%] P ΔRM (GABA) [%] P
IC Astrocyte +8.4 ± 3.6 (15) 0.018 n.s. sc +1.1 ± 4.4 (15) 0.403 n.s. sc
Neuron -97.9 ± 0.5 (11) 0.000 ***sc −98.9 ± 0.1 (11) 0.000 ***sc
HC Astrocyte +2.9 ± 4.0 (6) 0.252 n.s. sc −7.6 ± 1.1 (8) 0.000 ***sc
Neuron −41.2 ± 6.2 (4) 0.004 *sc −73.5 ± 5.7 (5) 0.000 ***sc
The data are given as mean ± SEM. The number of experiments is given in parenthesis. IC Inferior colliculus, HC Hippocampus, P Probability value, sc Šidák
corrected significance level for 3 comparisons, n.s. Not significant, *sc: P < 0.017, ***sc: P < 0.0003. For critical significance levels, see Methods section. ΔRM is
given for t1 (1 s after focal application of neurotransmitter)
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prolonged application, IGABA recovered occasionally to a
lower steady-state level in some recordings. Similar to
IGABA, GABA induced a reversible depolarization (IC:
ΔEM (GABA): 7.2 ± 0.8 mV, n = 7/7/7; HC: ΔEM (GABA):
10.6 ± 1.6 mV, n = 7/7/5; P = 0.041; Fig. 4b). Both IGABA
and ΔEM (GABA) indicate the presence of functional
GATs. Noticeably, GABA-induced transients were 2-4-
fold larger than the above-described glycine-induced
transients. In addition, this difference was more promin-
ent in HC astrocytes than in IC astrocytes (Table 2).
To assess the different GAT isoforms being expressed
in IC and HC astrocytes, we focally applied GABA and
analyzed the sensitivity of IGABA to the non-competitive
GAT-1 and GAT-3 antagonists NO711 and SNAP5114,
respectively (Fig. 5a1-2). The two antagonists reduced
IGABA (max) by about 20-40% (IC: NO711: 19 ± 4%, n = 4/
4/2, P = 0.007; SNAP5114: 22 ± 4%, n = 4/4/4, P = 0.003;
HC: NO711: 28 ± 6%, n = 8/8/5, P < 0.001; SNAP5114:
43 ± 6%, n = 7/7/4, P = 0.001; Fig. 5a3) showing the
presence of functional GAT-1 and GAT-3. NO711 and
SNAP5114 themselves had no effect on the membrane
current. Simultaneously inhibiting GAT-1 and GAT-3
led to an incomplete reduction of IGABA (max) (Fig. 5a1-2).
This can either result from a low antagonist concentra-
tion that was chosen in order to ensure specificity of the
substances or from the presence of further GATs, i.e.
GAT-2 (Slc6A13) and BGT-1 (Slc6A12) [16]. The latter
case was addressed analyzing transcripts for the four
cloned GATs in single astrocytes. All tested IC astrocytes
exhibited transcripts for GAT-1 and GAT-3, whereas
these transporters are present in about half of the HC
astrocytes. It has to be pointed out that transcripts for
GAT-1 and GAT-3 were found in 3/7 HC astrocytes,
whereas they were not detected in 3/7 cases. In those
cells transcripts for Kir4.1 were found, which proved
successful RNA extraction. One HC astrocyte expressed
only transcripts for GAT-1. However, transcripts for
GAT-2 and BGT-1 were only detected in the positive
Fig. 5 IC and HC astrocytes express GAT-1 and GAT-3. a: Focal application of GABA (1 mM, 0.5 s; triangles) elicited an IGABA (EH = −85 mV; a1-2).
The non-competitive antagonists for GAT-1 (NO711, 10 μM) and GAT-3 (SNAP5114, 40 μM) reduced IGABA (max) (a3). b: Single-cell RT-PCR revealed
transcripts for GAT-1 and GAT-3 in all IC astrocytes and about half of the HC astrocytes. Transcripts for GAT-2 and BGT-1 were never present. c:
Focal application of GABA (1 mM, 10 s; triangle) induced a long lasting inward current (EH = −85 mV; c1-2, top). Responses to test pulse (see Additional
file 2: Figure S2A) were used to calculate RM at t0, t1, t5, and t10 (c1-2, bottom). Upon GABA application, RM was transiently reduced exclusively in HC
astrocytes (c3). The number of recorded cells (n) is given within the diagrams. Shown are mean values ± SEM. Significance levels in panel c3 were Šidák
corrected for three comparisons (see Methods section). bp: base pairs
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control (Additional file 3: Figure S3), but not in indi-
vidual IC or HC astrocytes (IC: n = 3/2/2; HC: n = 7/
6/5; Fig. 5b).
Astrocytes, for example in the HC, express GABAARs
[21, 22]. Accordingly, IGABA (max) might be underesti-
mated if GABAAR-mediated Cl
− influx causes an out-
ward current that counteracts the GAT-mediated inward
current. To verify this, we performed fast and focal pres-
sure injection of GABA and assessed RM changes.
Positive controls on GABAAR expressing IC and HC
neurons [30, 50, 52] showed the suitability of the experi-
mental configuration to reveal GABAAR activation. Focal
GABA application induced a transient, fast declining out-
ward current (Additional file 2: Figure S2C1, E1). This was
paralleled by strong increase in the offset current induced
by the test pulses resembling an eminent reduction of RM
(IC: t1: −98.9 ± 0.1%, n = 11/6/6, P < 0.001; HC: t1: −73.5 ±
5.7%, n = 5/3/2, P < 0.001; Additional file 2: Figure S2C2-3,
Additional file 2: Figure S2E2-3). In the prolonged presence
of GABA, RM of IC neurons recovered partially indicating
minimal desensitization of GABAARs (t10: −96.4 ± 0.4% of
resting RM, P < 0.001 compared to t0; P < 0.001 compared
to t1; Additional file 2: Figure S2C3) as previously reported
[50]. In contrast, RM of CA1 pyramidal cells recovered
completely indicating strong desensitization of GABAARs
(t10: +2.8 ± 9.4% of resting RM, P = 0.250 compared to t0;
P = 0.003 compared to t1; Additional file 2: Figure S2E3) as
previously reported [53, 54].
Subsequently, we did focal application and analyzed pu-
tative GABAAR-mediated RM changes in IC and HC astro-
cytes (Fig. 5c). At any time, GABA induced an inward but
no outward current (Fig. 5c1-2). In IC astrocytes, the offset
current induced by the test pulses did not change (Fig.
5c1). Accordingly, at t1RM was not reduced (+1.1 ± 4.4%,
n = 15/5/5, P = 0.403; Fig. 5c3). Thus, RM was GABA-
independent arguing against an activation of GABAARs. In
HC astrocytes however, GABA increased the offset current
in response to the test pulses (Fig. 5c2). In turn, RM was re-
duced (t1: −7.6 ± 1.1%, n = 8/5/2, P < 0.001; Fig. 4c3) demon-
strating activation of GABAARs in HC astrocytes. In the
prolonged presence of GABA, RM recovered completely,
indicating desensitization of GABAARs (t10: −2.4 ± 1.3% of
resting RM, P = 0.055 compared to t0; P < 0.001 compared
to t1; Fig. 5c3). Thus, IGABA (max) was not contaminated by
GABAAR activation as it was not determined within the
first 10 s of GABA wash-in. Taken together, IC and HC
astrocytes co-expressed functional GAT-1 and GAT-3,
whereas GABAARs were only found in HC astrocytes. Data
are summarized in Tables 2 and 3.
Region-dependent transporter kinetics
As we observed that the IGABA (max)/IGly (max) ratio was
larger in HC compared to IC (Table 2) we speculated
about putative additional differences between those
nuclei regarding transporters kinetics. Thus, we analyzed
rise time (10 - 90%) and decay time (90 - 10%) of IGly and
IGABA in IC and HC astrocytes resulting from focal appli-
cation of glycine and GABA (Fig. 6a1, b1). The rise time of
IGly was much shorter in HC astrocytes (IC: 1.32 ± 0.08 s,
n = 12/5/5; HC: 0.70 ± 0.15 s, n = 8/7/4; P = 0.002; Fig. 6a2).
Additionally, the decay time of IGly was shorter in
HC astrocytes, too (IC: 11.83 ± 0.83 s, n = 12/5/5; HC:
8.35 ± 0.64 s, n = 8/7/4; P = 0.002; Fig. 6a3). Together,
HC astrocytes exhibited faster kinetics for IGly.
Similarly, we analyzed the kinetics of IGABA (Fig. 6b).
Here, IC astrocytes exhibited a much shorter rise time
(IC: 1.15 ± 0.10 s, n = 8/8/8; HC: 2.29 ± 0.27 s, n = 19/19/6;
P < 0.001; Fig. 6b2). The decay time of IGABA was not
different between IC and HC astrocytes (IC: 12.29 ± 0.68 s,
n = 8/8/8; HC: 11.17 ± 0.54 s, n = 19/19/6; P = 0.123;
Fig. 6b3). Taken together, our data demonstrate that
transporter-mediated currents were heterogeneous
with respect to glycine and GABA as well as the
brain region. HC astrocytes exhibited faster IGly kinetics,
whereas IC astrocytes partially showed faster IGABA kinet-
ics. Data are summarized in Table 4.
In summary, our results show that SR101-labeled cells
in the IC and HC exhibited properties of classical astro-
cytes. In all IC and about half of the HC astrocytes,
GlyT1, GAT-1, and GAT-3 were present, whereas GlyT2,
GAT-2, and BGT-1 were not found. In both regions, as-
trocytes exhibited a stronger GAT than GlyT activity.
However, in HC astrocytes the IGABA (max)/IGly (max) ratio
was remarkably higher. In comparison to IC astrocytes
HC astrocytes showed faster kinetics for the transport of
glycine and slower kinetics for the transport of GABA.
Finally, GlyRs could not be detected in astrocytes of IC
and HC. However, expression of GABAARs was hetero-
geneous – it was found in HC but not in IC astrocytes.
Discussion
In the present study, we investigated the expression and
function of GlyTs and GATs in astrocytes from IC and
HC. In both regions, astrocytes generally expressed the
three inhibitory neurotransmitter transporters GlyT1,
GAT-1 and GAT-3, whereas GlyT2, GAT-2, and BGT-1
were not detected. Remarkably, IC astrocytes exhibited
larger IGly (max) and smaller IGABA (max) compared to HC
astrocytes. In turn, this resulted in a higher IGABA (max)/
IGly (max) ratio in HC astrocytes.
Basic properties of IC and HC astrocytes
Astrocytes were labeled with SR101, by which classical astro-
cytes in acute tissue slices – containing the superior olivary
complex (SOC) or the HC – can be identified [19, 41, 42,
55]. We mentioned before that in the IC SR101 labels small
sized and highly branched cells [19]. However, their identity
was not verified yet by electrophysiological recordings. Here
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we show that SR101-labeled IC cells exhibit a highly negative
EM and a low RM. They are not NG2 glia as these exhibit
completely different electrophysiological properties, i.e. a
more positive EM, a tremendously higher RM, and currents
through voltage-activated sodium channels [42, 56–58]. Fur-
thermore, they are unlikely to be oligodendrocytes as they
are if at all just weakly labeled by SR101 [41]. In contrast,
SR101-labeled IC cells exhibited a non-linear or linear
current-voltage relationship corresponding to non-passive
and passive astrocytes, respectively, which are found through-
out the auditory brainstem (Fig. 1) [19, 41, 55, 59, 60]. Fur-
thermore, these from now on IC astrocytes-termed cells
were distributed homogeneously within the nucleus (Fig. 1)
like astrocytes in SOC nuclei [19, 41]. HC astrocytes exhib-
ited properties like reported in previous studies, e.g. [42, 56].
IC and HC astrocytes express functional GlyT1, GAT-1, and
GAT-3
Glycine and GABA activate respective transporters that me-
diate an inward current and a concomitant depolarization
due to their stoichiometry: 1 glycine/1 GABA: 2 Na+: 1 Cl−
[15, 17]. Both inward current and depolarization sometimes
partially recovered in the prolonged presence of the agonist
(Figs. 2 and 4). This was observed before in LSO astrocytes
and may be due to a reduced driving force [19]. Both IC
and HC astrocytes showed sarcosine-sensitive IGly (max),
demonstrating the presence of functional GlyT1 (Fig. 3).
Sarcosine is a competitive agonist and therefore inhibited
just about 60-70% of IGly (max) [61]. Thus, the co-expression
of the neuron-typical GlyT2 could not be excluded per se.
GlyT2 was reported to be present occasionally in astrocytes
[40, 49]. However, here we never found transcripts for
GlyT2 in IC and HC astrocytes indicating the absence of
GlyT2. GlyT1 mRNA was present in all IC astrocytes suffi-
ciently explaining IGly. However, GlyT1 transcripts were
found only in about half of the HC astrocytes (Fig. 3). There
are several possible explanations: 1) Although the scRT-
PCR reliably detected GlyT1 transcripts in the positive con-
trols, it was eventually not sensitive enough to detect single
transcripts in all HC astrocytes. 2) There is effectively a
mosaic expression of GlyT1. However, all recorded HC
astrocytes exhibited an IGly (Fig. 2). Thus, HC astrocytes
Table 4 Kinetics of glycine- and GABA-induced currents in IC and HC astrocytes
Region IGly IGABA
Rise time [s] P Decay time [s] P Rise time [s] P Decay time (s] P
IC 1.32 ± 0.08 (12)
0.002**
11.83 ± 0.83 (12)
0.002**
1.15 ± 0.10 (8)
0.000***
12.29 ± 0.68 (8) 0.123
n.sHC 0.70 ± 0.15 (8) 8.35 ± 0.64 (8) 2.29 ± 0.27 (19) 11.17 ± 0.54 (19)
The data are given as mean ± SEM. The number of experiments is given in parenthesis. IC Inferior colliculus, HC Hippocampus, P Probability value, n.s. Not significant
**: P < 0.01, ***: P < 0.001
Fig. 6 Region-dependent kinetics of IGly and IGABA. a: IGly kinetics. Focal application of glycine (1 mM, 0.5 s; triangles) elicited an IGly (EH = −85 mV) in
IC (left) and HC (middle) astrocytes. Merged traces were peak aligned (right; a1). IC astrocytes exhibited longer rise time (a2; 10-90) and decay time
(a3; 90-10) compared to HC astrocytes. b: IGABA kinetics. Focal application of GABA (1 mM, 0.5 s; triangles) elicited an IGABA (EH = −85 mV) in IC (left)
and HC (middle) astrocytes. Merged traces were peak aligned (right; b1). IC astrocytes exhibited a shorter rise time compared to HC astrocytes (b2).
The decay time was not significantly different (b3). The number of recorded cells (n) is given within the diagrams. Shown are mean values ± SEM
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putatively express further transporters that are capable to
transport glycine. The neutral amino acid transporter
ASCT2 (Slc1A5) as well as sodium-coupled neutral amino
acid transporters (system N) SNAT3 (Slc38A3) and SNAT5
(Slc38A5) are expressed by astrocytes and transport glycine,
but are electroneutral and accordingly do not generate cur-
rents [62–65]. 3) HC astrocytes are extensively coupled
[66–69] and allow direct electrical communication between
neighboring astrocytes [70–72]. Here, about half of the HC
astrocytes lacked GlyT1 expression, but can be expected to
be surrounded by and coupled to GlyT1 expressing HC
astrocytes. Therefore, GlyT1 negative astrocytes might in-
directly experience IGly.
Likewise, IC and HC astrocytes exhibited NO711- and
SNAP5114-sensitive IGABA (max) showing the co-expression
of functional GAT-1 and GAT-3 in both regions (Fig. 5).
Hitherto, in the HC GAT-1 and GAT-3 were attributed to
interneurons and astrocytes, respectively [21, 37]. To our
surprise, we found prominent expression of functional
GAT-1 in HC astrocytes. NO711 and SNAP5114 inhibited
IGABA (max) by about 20 to 40% (Fig. 5), which is similar to
our former study on LSO astrocytes [19]. However, simul-
taneous administration of NO711 and SNAP5114 did not
completely abolish IGABA (max) (Fig. 5). Both antagonists
dose-dependently inhibit respective GATs [21]. As we here
used a low drug concentration to retain the specificity of
GAT inhibitors [16] it was not expected to achieve a
complete blockage. However, to that point our data did
not exclude the possibility of co-expression of further
GATs, such as GAT-2 or BGT-1. The latter are pre-
dominantly found at the meninges and neuronal
somata, respectively [16]. In accordance, we found only
transcripts for GAT-1 and GAT-3 but not for GAT-2
and BGT-1 in IC and HC astrocytes. These results indi-
cate that IGABA was solely mediated by GAT-1 and
GAT-3 (Fig. 5). Surprisingly, GAT-1 and GAT-3 mRNA
exhibited a mosaic pattern in HC astrocytes. In 3/7
cases HC astrocytes did not exhibit transcripts for any
GAT. There are two possible explanations: 1) Although
the scRT-PCR detected transcripts in the positive controls,
it was not sensitive enough to detect single transcripts on
the single cell level. 2) There is effectively a mosaic expres-
sion pattern. However, the second explanation contrasts
with the finding that all HC astrocytes exhibited IGABA
that was always sensitive to the GAT-1 and GAT-3 inhibi-
tor NO711 and SNAP5114, respectively (Figs. 4 and 5).
Again, the extensive coupling of and direct electrical com-
munication between HC astrocytes [66–72] could explain
why IGABA was recorded in all cells independent from
GAT expression.
The co-expression of GlyTs and GATs in the same
astrocyte raises the question of transporter interference.
Such interference of different transporters was seen be-
fore [6, 73, 74]. In a previous study on LSO astrocytes,
we could show that GlyT and GAT activity influence
each other [19]. The reciprocal reduction of activity
likely refers to changes in their commonly used gradi-
ents for Na+ and Cl−. Those gradients become weakened
upon transporter activation thereby reducing the driving
force for the transport. Especially in the IC, where neu-
rons simultaneously receive glycinergic and GABAergic
synaptic inputs [29, 30], transporter interference might
occur during synchronous activation of astrocytic GlyTs
and GATs [15]. However, it remains to be elucidated to
which extend this interplay takes place and how altered
neurotransmitter clearance putatively modulates neur-
onal signaling [15, 17, 18].
Taken together, all IC and about half of the HC astro-
cytes expressed functional GlyT1, GAT-1, and GAT-3. In
this respect, these astrocytes can express the same com-
bination of inhibitory neurotransmitter transporters like
astrocytes located in LSO, thalamus, cortex or Bergmann
glia in the cerebellum or Müller cells in the retina [15,
19, 75–80]. The potentially heterogeneous expression in
HC astrocytes could be indicative of functional domains
in which glycinergic transmission arising from excitatory
projections and GABAergic transmission from interneu-
rons are segregated from each other.
Transporter currents are not contaminated by ionotropic
receptor activation
Both glycine and GABA act on respective transporters
and ionotropic receptors. While activation of GlyTs and
GATs by exogenous accessible neurotransmitters neces-
sarily causes an inward current, activation of GlyRs and
GABAARs can result in either an inward current or an
outward current. The underlying Cl− efflux or influx de-
pends on [Cl−]i and subsequently on ECl. Under physio-
logical conditions astrocytic [Cl−]i amounts to about
30 mM [81] causing an inward current and concomitant
depolarization upon receptor activation. However, our
pipette solution contained 2 mM Cl− and receptor
activation would have caused an outward current. In our
recordings, we never observed glycine- or GABA-induced
outward currents in IC and HC astrocytes (e.g. Figs. 2 and
4), which was surprising as at least HC astrocytes express
functional GABAARs [21, 22]. Two possible scenarios
could explain this discrepancy: 1) The GABAAR-mediated
outward current was too small and consecutively masked
by the large GAT-mediated inward current. This in turn
would suggest that the amount of GAT-mediated inward
current would be underestimated. 2) GABAARs rapidly
desensitize [53, 54, 82]. In combination with slow wash-in
of GABA in our experiments, this early desensitization
might hamper the accurate detection of GABAAR activa-
tion. To answer the question of masked activation and/or
desensitization of ionotropic receptors we measured RM
changes that could result from increased membrane
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permeability (see Methods). Proof of principle experi-
ments on GlyR and GABAAR expressing IC and HC neu-
rons validated the method (Additional file 2: Figure S2).
Our results convincingly demonstrated the capability to
detect RM changes upon GlyR and GABAAR activation
with the utilized test pulse protocol.
With this tool at hand, we were able to detect
GABAAR activation in HC astrocytes (Fig. 5). GABAAR
activation was detected by temporary RM reduction that
vanished within 10 s indicating receptor desensitization.
However, we never observed any outward current that
had to arise from Cl− influx due to the low [Cl−]i of the
intracellular solution. We reason that any small Cl−
influx-mediated outward current is instantly masked by
strong electrogenic transporter current. Nonetheless,
IGABA (max), which was measured earliest after 10 s, was
not contaminated by GABAAR-mediated currents. The
RM reduction in HC astrocytes was rather small (~8%)
compared to HC neurons (~74%). Astrocytes express
various K+ channels that are constitutively open at rest-
ing conditions (inwardly rectifying K+ channels, two-
pore-domain K+ channels) [46, 83]. In turn, these chan-
nels cause the very high K+ conductance observed in as-
trocytes [44]. Accordingly, it is not surprising that the
RM reduction was relatively small. At the same time, IC
astrocytes exhibited no RM reduction upon GABA appli-
cation (Fig. 5). Thus, either GABAARs are absent or
their amount is essentially not high enough to be rele-
vant. Interestingly, using this method on LSO astrocytes
we detected a small RM reduction indicating the pres-
ence of GABAARs (Vanessa Augustin and Simon Wadle,
unpublished). We previously reported that IGABA in LSO
astrocytes mainly constitutes of GAT-mediated current
[19]. Similar to HC astrocytes, the GABA-induced RM
reduction in LSO astrocytes vanished within 10 s after
the beginning of GABA application. Thus, our previ-
ously reported IGABA (max) in LSO astrocytes was not
contaminated by GABAAR activation.
Similarly, we used the same method to examine a pos-
sible influence of GlyR activation onto our recorded IGly
(max). We could show that neither IC nor HC astrocytes
exhibited glycine-induced RM changes or outward
currents (Figs. 2 and 3). Likewise, LSO astrocytes lack
glycine-induced RM changes (Vanessa Augustin and
Simon Wadle, unpublished). Accordingly, functional
GlyRs appear to be absent in those astrocytes. This is
consistent with the observation that GlyRs were de-
scribed only in astrocytes located in most caudal brain
regions, i.e. spinal cord and caudal brainstem (ventral re-
spiratory group) [20, 24, 25]. However, this contrasts
with the wide distribution of GABAARs throughout the
brain [22]. In summary, IGly (max) and IGABA (max) were not
affected by GlyRs and GABAARs, respectively, and the
transporter currents were accordingly not underestimated.
Activity and kinetics of GlyTs and GATs
IC and HC astrocytes are differently capable to take up
glycine and GABA (Table 2). While there is no statistical
difference for glycine transport among the two brain re-
gions, the GABA transport is stronger in HC astrocytes.
In the LSO, which is located more caudal compared to IC
and HC, astrocytes exhibit a similar capability to take up
glycine. However, their ability for GABA clearance is
much lower [19]. Thus, astrocytic IGABA (max) increases
from caudal to rostral brain regions (LSO < IC <HC).
Consequently, the ratio of IGABA (max)/IGly (max) is elevated
in more rostral brain regions (HC (3.6) > IC (1.9) > LSO
(1.6; data from [19])). This was expected, as the need to
take up GABA rather than glycine is higher in rostral
brain regions, which arises from the glycine-to-GABA
shift as the predominant inhibitory neurotransmitter [2, 3,
9, 10, 29, 30]. Noticeably, GlyT-mediated IGly (max) sub-
stantially persists in HC astrocytes. This allows the clear-
ance of glycine that is co-released from excitatory
presynaptic terminals [11, 12]. Taken together, IGly (max) is
similar in the three brain regions, whereas IGABA (max) as
well as the IGABA (max)/IGly (max) ratio are region-
dependent and increases with the prevalence of GABA as
inhibitory neurotransmitter.
Beside inter-region differences of amplitudes, we add-
itionally found region-dependent alterations of the kinet-
ics of transporter-mediated currents (Table 4). Whereas
IC astrocytes exhibit similar kinetics for the transport of
glycine and GABA, HC astrocytes are marked by faster
glycine and slower GABA transport. However, LSO as-
trocytes generally outperform IC and HC astrocytes re-
garding kinetics of GlyTs (rise time: 1.05 ± 0.18 s; decay
time: 4.88 ± 1.11 s; n = 6/6/6) and GATs (rise time: 0.61
± 0.13 s; decay time: 4.52 ± 0.52 s; n = 12/12/11; data
from [19]). GlyTs and GATs can be modulated by several
mechanisms: e.g., enhancement of transporter activity
can be achieved by transporter glycosylation and [Ca2+]i
elevation [84–86], whereas decrease of transporter activ-
ity can be caused by activation of protein kinase C and
de-glycosylation [84, 85, 87–89]. If one or more of those
mechanisms are relevant in astrocytes of the three brain
regions, is yet unexplored. However, the different trans-
port kinetics correlate with different precision of signal
processing in those three brain regions. The auditory
system in general requires temporal precise coding to
compute correctly e.g. interaural time and level
differences in the medial superior olive and the LSO,
respectively, and synapses show relatively weak depres-
sion allowing high rates of synaptic transmission [4, 90–
92]. Furthermore, the synaptic signaling in the LSO is
considerably faster and more precise compared to the
hippocampus [93]. Like the LSO, the IC belongs to the
auditory brainstem. However, it is not used for sound
source localization, but serves as an information hub.
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Thus, the IC can tolerate a slower and less precise syn-
aptic transmission. As the rate of neurotransmitter
transporter activity determines the extent of synaptic
transmission [17, 18], the fast transmitter uptake into
LSO astrocytes to terminate quick synaptic transmission
is in favor of fast and precise neuronal signaling. In con-
trast, synaptic transmission in IC and HC is not as pre-
cise and neurotransmitter uptake is not that fast. Thus,
our data suggest that expression and kinetics of astro-
cytic inhibitory neurotransmitter transporters are ad-
justed to the requirements of local circuitry.
Conclusion
In summary, our results demonstrate the expression of
functional GlyT1, GAT-1, and GAT-3 in all IC astrocytes
and about half of the HC astrocytes. In both regions the
activity of GATs is stronger compared to the activity of
GlyTs. Whereas IGly (max) is comparable in both regions,
IGABA (max) is much larger in HC astrocytes. Accordingly,
the IGABA (max)/IGly (max) ratio is markedly elevated in HC
astrocytes. Furthermore, astrocytic GlyTs and GATs in IC
as well as HC exhibit slower transporter kinetics in com-
parison to those transporters in LSO astrocytes, thereby
reflecting the regionally differing demands for temporal
precision of synaptic transmission. Altogether, our results
show that astrocytes do not uniformly express inhibitory
neurotransmitter transporters, but region specifically
adapt to the requirements of local circuitry.
Additional files
Additional file 1: Figure S1. Basic characterization of IC and HC neurons.
A: Reconstruction of a single IC and HC neuron. Dendrite topography of the
IC neuron correlated with isofrequency bands (dorsomedial to ventrolateral
orientation; A1). Basal and apical dendrites from CA1 pyramidal cell extended
into stratum oriens (SO) and stratum radiatum (SR), respectively (A2). B: Neurons
were clamped to EH =−70 mV and were stepwise hyper- and depolarized
from −150 mV to +50 mV, with 10 mV increments. IC (B1) and HC (B2) neurons
expressed voltage-dependent early inward and delayed outward currents.
Inset: higher temporal resolution of inward currents. Scale bars: 1 ms.
(TIFF 1876 kb)
Additional file 2: Figure S2. Glycine and GABA induced RM reduction
in IC and HC neurons. A: Voltage-clamp protocol including 11 test pulses
(t0-10). B-E: Neurons were clamped to EH = −70 mV. Focal application of
glycine or GABA (1 mM, 10 s; triangles) induced a transient outward
current (B1-E1). Responses to test pulses at t0, t1, t5, and t10 (B2-E2) allowed
calculation of RM. Upon glycine or GABA application RM was reduced in
IC and HC neurons (B3-E3). n represents the number of recorded cells.
Shown are mean values ± SEM. Significance levels in panels B3-E3 were
Šidák corrected for three comparisons (see Methods section). (TIFF 2112 kb)
Additional file 3: Figure S3. Controls for single-cell RT-PCR. Random
RNA prepared from brainstem served as positive control (p.c.). For negative
control (n.c.) a patch pipette was dipped into ACSF and was placed closely
to the surface of the slice without patching a cell. All targeted mRNAs were
detected in p.c., whereas the n.c. was free of signals. (TIFF 1434 kb)
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